Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?
- 9 September 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 34 (1) , 34-43
Abstract
Heart failure is still a major cause of hospitalization and mortality in developed countries. Many clinical trials have tested the use of multipotent stem cells as a cardiac regenerative medicine. The benefit for the patients of this therapeutic intervention has remained limited. Herein, we review the pluripotent stem cells as a cell source for cardiac regeneration. We more specifically address the various challenges of this cell therapy approach. We question the cell delivery systems, the immune tolerance of allogenic cells, the potential proarrhythmic effects, various drug mediated interventions to facilitate cell grafting and, finally, we describe the pathological conditions that may benefit from such an innovative approach. As members of a transatlantic consortium of excellence of basic science researchers and clinicians, we propose some guidelines to be applied to cell types and modes of delivery in order to translate pluripotent stem cell cardiac derivatives into safe and effective clinical trials. Stem Cells 2016;34:34–43Keywords
This publication has 93 references indexed in Scilit:
- Metabolic Plasticity in Stem Cell Homeostasis and DifferentiationCell Stem Cell, 2012
- The Permeability Transition Pore Controls Cardiac Mitochondrial Maturation and Myocyte DifferentiationDevelopmental Cell, 2011
- Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear ReprogrammingCell Metabolism, 2011
- Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine modelGene Therapy, 2011
- Short-Term Immunosuppression Promotes Engraftment of Embryonic and Induced Pluripotent Stem CellsCell Stem Cell, 2011
- Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signalsCell Research, 2010
- p53 connects tumorigenesis and reprogramming to pluripotencyJournal of Experimental Medicine, 2010
- Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenograftsProceedings of the National Academy of Sciences, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006